Prognoses of patients with melanoma who continue/discontinue anti-programmed death-1 therapy after achieving a complete response in a real-world setting: a multicentre retrospective study.
Junji KatoKenjiro NamikawaJiro UeharaMotoo NomuraYasuhiro NakamuraHisashi UharaHiroshi UchiShusuke YoshikawaYukiko KiniwaYoshiyuki NakamuraTakuya MiyagawaShigeto MatsushitaTatsuya TakenouchiNaohito HattaFumitaka OhnoTaku MaedaSatoshi FukushimaNaoya YamazakiPublished in: The British journal of dermatology (2022)